Division of Urology, University of New Mexico School of Medicine, Albuquerque, New Mexico 87131, USA.
J Urol. 2011 Sep;186(3):855-9. doi: 10.1016/j.juro.2011.04.079. Epub 2011 Jul 23.
SEER (Surveillance, Epidemiology and End Results) is the leading source of population level data on prostate cancer, including the positive surgical margin incidence at radical prostatectomy. Recently studies showed wide ranges in positive surgical margin rates among individual registries, which we hypothesized was the result of coding inaccuracies. Thus, we systematically audited SEER prostate cancer data.
The New Mexico Tumor Registry, a SEER core registry, was queried for incident prostate cancer cases in 2007 that met certain criteria, including 1) adenocarcinoma histology, 2) malignant behavior and 3) radical prostatectomy as the first course of therapy. Pathological stage codes were audited by examining original radical prostatectomy pathology reports in accordance with SEER coding guidelines. The incidence and sites of positive surgical margins were critically analyzed.
Of the 305 cases that met all study inclusion criteria with complete source documents available 92 (30%) were coded incorrectly. The most common error was failure to properly account for surgical margin status (46 of 92 cases or 50%). The incidence of positive surgical margins in organ confined disease cases was 13% by SEER coding rules but 28% by a more clinical definition of positive surgical margins (p<0.001). In organ confined cases positive surgical margins occurred principally at the apex but in nonorgan confined cases most were multifocal.
In this SEER registry 30% of radical prostatectomy cases in 2007 were coded inaccurately. SEER coding guidelines result in underestimating the positive surgical margin incidence. Clinicians and investigators should recognize the limitations of tumor registry data on positive surgical margins.
SEER(监测、流行病学和最终结果)是前列腺癌人群水平数据的主要来源,包括前列腺癌根治性切除术的阳性手术切缘发生率。最近的研究表明,个别登记处的阳性手术切缘率存在广泛差异,我们假设这是由于编码不准确造成的。因此,我们系统地审核了 SEER 前列腺癌数据。
新墨西哥肿瘤登记处是 SEER 的核心登记处,对 2007 年符合某些标准的前列腺癌病例进行了查询,包括 1)腺癌组织学,2)恶性行为和 3)根治性前列腺切除术作为一线治疗。病理分期代码是通过根据 SEER 编码指南检查原始根治性前列腺切除术病理报告来审核的。对阳性手术切缘的发生率和部位进行了批判性分析。
在符合所有研究纳入标准且有完整源文件的 305 例病例中,有 92 例(30%)编码不正确。最常见的错误是未能正确记录手术切缘状态(92 例中有 46 例,占 50%)。根据 SEER 编码规则,器官局限疾病病例的阳性手术切缘发生率为 13%,而根据更具临床意义的阳性手术切缘定义,阳性手术切缘发生率为 28%(p<0.001)。在器官局限病例中,阳性手术切缘主要发生在尖端,但在非器官局限病例中,大多数是多灶性的。
在这个 SEER 登记处,2007 年有 30%的根治性前列腺切除术病例编码不准确。SEER 编码指南导致对阳性手术切缘发生率的低估。临床医生和研究人员应认识到肿瘤登记处关于阳性手术切缘数据的局限性。